The most used glucose monitoring systems are real-time CGMs, some of which are called adjunctive, i.e., the user has to measure the blood glucose level with a glucometer to decide on the treatment, such as insulin dose or treatment of hypoglycemia, while the non-adjunctive types do not require calibration [12-14]. The gene discussed is INS; the disease is Hypoglycemia.